If you recently tested positive for #COVID19 , volunteer in #ClinicalResearch like the #ACTIV6Study and help advance knowledge on at-home COVID treatments to help people #FeelBetterFaster .
Learn more: activ6study.org

In this remote #ClinicalTrial , people who test positive for #COVID19 can enroll online and have study drugs mailed to them. Surveys about how they feel can be completed online or by phone. Learn more: activ6study.org
#FeelBetterFaster NCATS PCORnetwork

Thanks to #ACTIV6Study participants and all those who support the study, we are able share results from what we are learning. Visit activ6study.org/study-results/ to learn more!

#FeelBetterFaster PCORnetwork NCATS

Tested positive for #COVID19 ? Enroll in #ACTIV6Study , a remote #ClinicalTrial studying existing medications for treating COVID-19. Take part in this clinical trial from home and contribute to knowledge about COVID!
activ6study.org

PCORnetwork NCATS

MMG attended the #MMMAwards in NYC. MMG in collaboration with Duke Clinical Research Institute ACTIV-6 Research Study were a finalist in the category of “Use of Clinical Trial/Research Marketing”. We won the gold award to take first place! We are so proud of the passion that our team members bring to the table.

#ACTIV6Study has opened a new arm testing #metformin , a medicine approved to treat diabetes. Learn more from NCATS about metformin and its potential for treating #COVID19 symptoms and preventing #LongCOVID .

ncats.nih.gov/pubs/features/…

Dr. Hernandez is presenting some of the notable studies powered by PCORnetwork that showcase the work of this network of networks funded by The Patient-Centered Outcomes Research Institute.

Listen in: pcori.me/451LtIz

#PCORI23

#ACTIV6Study is committed to sharing what we are learning. Visit our website to read study findings so far and learn about how you can get involved in this remote clinical trial seeking at-home treatments for #COVID19 . #FeelBetterFaster
activ6study.org/study-results/

Adults who test positive for #COVID19 can enroll in #ACTIV6Study from home and have study materials shipped directly to them. Participation in this #ClinicalTrial can help researchers learn more about COVID-19 treatments outside the hospital. activ6study.org

PCORnetwork

Findings from the fluticasone arm of #ACTIV6Study have been published in the New England Journal of Medicine. Thank you to all study participants who made this research possible! Read these and more study results: activ6study.org/study-results/

Eligible to participate in #ACTIV6Study ? Participants must be 30+ years old and have mild-to-moderate #COVID19 . If you’re COVID-positive, enroll today to contribute to research that can change the future of COVID treatment! activ6study.org
#FeelBetterFaster

Tested positive for #COVID19 ? Enroll in #ACTIV6Study , a remote #ClinicalTrial studying existing medications for treating COVID. Take part in this clinical trial from home and contribute to knowledge about COVID treatment! | activ6study.org

PCORnetwork NCATS

#ACTIV6Study results on #fluticasone for at-home treatment of #COVID19 symptoms have been published in NEJM. Researchers found no evidence that fluticasone shortened time to recovery. Read: nejm.org/doi/full/10.10…

Duke Clinical Research Institute @PCORNetwork NCATS

glad to have this arm out!

⁦ACTIV-6 Research Study⁩ shows how decentralized platform can evaluate multiple drugs for #covid19 . Great collaborations along the way

⁦David Boulware, MD MPH⁩

Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19 | NEJM nejm.org/doi/full/10.10…

New ACTIV-6 trial results published today in the NEJM show no benefit to taking fluticasone for mild-to-moderate COVID-19 symptoms. Read on to learn more about the results and the DCRI’s COVID-19 research: dcri.org/activ-6-trials…

We still need to find treatments for #COVID19 outside of the hospital. #ACTIV6Study opened a new arm testing metformin for its effectiveness in treating COVID symptoms. Learn more: activ6study.org

#FeelBetterFaster Duke Clinical Research Institute PCORnetwork NCATS

In the fluvoxamine 100 arm of #ACTIV6Study , 46% of participants identified as Hispanic/Latino. Study PI Adrian “WE NEED RCTS!” Hernandez emphasizes the importance of #diversity among #ClinicalTrial participants to ensure results can help everyone #FeelBetterFaster . corporate.dukehealth.org/news/study-con…

The ACTIV-6 Research Study led by the DCRI found no clinical benefit to taking 100 mg of fluvoxamine twice daily for the treatment of mild-to-moderate COVID-19 symptoms. Read #StudyResults from this NIH #ClinicalTrial : dcri.org/study-confirms…

The #ACTIV6Study found no clinical benefit to taking 100 mg of fluvoxamine twice daily for the treatment of mild-to-moderate COVID-19 symptoms. Read #StudyResults from this NIH clinical trial: corporate.dukehealth.org/news/study-con…

#FeelBetterFaster Duke Clinical Research Institute PCORnetwork NCATS

Adults who test positive for #COVID19 can enroll in #ACTIV6Study from home and have study materials shipped directly to them. Participation in this #ClinicalTrial can help researchers learn more about COVID-19 treatments outside the hospital.

activ6study.org